27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Major biotech and pharmaceutical companies such as AstraZeneca PLC (NASDAQ:AZN) and Pfizer Inc. (NYSE:PFE) have been some of the best investments to make throughout the COVID-19 pandemic.
Let’s take a look at some of the major players in the biotech industry and see how they are moving today:
AstraZeneca:
AstraZeneca is trading 3.5% higher at $59.67 after the company annoucned it is acquiring Caelum Biosciences for $500 million. AstraZeneca is making this move to further its foothold in the rare disease market.
Pfizer:
Pfizer was trading slightly higher for much of Wednesday morning, and then shot up nearly half of a percent in the afternoon. The company announced top-line results from a Phase 3 study evaluating the safety and immunogenicity of PREVNAR 20 in adults 65 years of age or older when administered at the same time as the seasonal influenza vaccine.
The stock was trading about 1% higher at $43.51 per share at the time of publication.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!